Clinical Trial Update: Effectiveness and Safety of Lactobacillus Rhamnosus Lcr35® in the Treatment of Recurrent Aphthous Stomatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the effectiveness and safety of Lactobacillus rhamnosus Lcr35 for treating recurrent aphthous stomatitis; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphthous Stomatitis

Drugs mentioned

• Lactobacillus rhamnosus Lcr35 (Lactobacillus rhamnosus Lcr35)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Aphthous Stomatitis | Phase 2 | Status: COMPLETED